naphazoline/pheniramine ophthalmic (OTC)

Brand and Other Names:Naphcon-A, Opcon-A, more...Visine-A
  • Print

Dosing & Uses

AdultPediatric

Dosage Forms & Strengths

naphazoline/pheniramine

ophthalmic solution

  • 0.025%/0.3%
  • 0.027%/0.3%

Allergic Conjunctivitis

Instill 1-2 drops in affected eye(s) up to 4 times daily

Other Information

Remove contact lenses before using

Store at room temp; protect from light and excessive heat; use before expiration date

Dosage Forms & Strengths

naphazoline/pheniramine

ophthalmic solution

  • 0.025%/0.3%
  • 0.027%/0.3%

Allergic Conjunctivitis

<6 years: Not established

6 years or older: 1-2 drops in affected eye(s) up to 4 times daily

Other Information

Remove contact lenses before using

Store at room temp; protect from light and excessive heat; use before expiration date

Next:

Adverse Effects

Frequency Not Defined

Stinging/tingling sensation upon instillation

Mydriasis

Ocular erythema

Previous
Next:

Warnings

Contraindications

Hypersensitivity

Cautions

Cardiac disease

Hypertension

Benign prostatic hypertrophy

Narrow angle glaucoma

Previous
Next:

Pregnancy & Lactation

Pregnancy Category: C

Lactation: Unknown whether distributed in breast milk, weigh benefits against risks

Pregnancy Categories

A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA: Information not available.

Previous
Next:

Pharmacology

Absorption: Negligible systemic absorption

Mechanism of Action

Naphazoline: alpha-adrenergic agonist (decongestant)

Pheniramine: H1 blocker (antihistamine)

Previous
Next:

Images

BRAND FORM. UNIT PRICE PILL IMAGE
Opcon-A ophthalmic (eye)
-
0.02675-0.315 % drops
Naphcon-A ophthalmic (eye)
-
0.025-0.3 % drops
Naphcon-A ophthalmic (eye)
-
0.025-0.3 % drops
Eye Allergy Relief (naphazoline-pheniramine)
-
0.025-0.3 % drops
Eye Allergy Relief (naphazoline-pheniramine)
-
0.025-0.3 % drops

Copyright © 2010 First DataBank, Inc.

Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.